. . . . . . . "[Patients with chronic myeloid leukemia in chronic phase who achieve early molecular response (EMR; generally defined as BCR-ABL ? 10% on the International Scale at 3 or 6 months) have improved outcomes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:10:13+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .